Literature DB >> 22777531

Benign multiple sclerosis: does it exist?

Jorge Correale1, María C Ysrraelit, Marcela P Fiol.   

Abstract

Although the definition of benign multiple sclerosis (BMS) remains controversial, it is generally applied to a subgroup of MS patients showing little disease progression, with minimal disability decades after disease onset, and is based mainly on changes in motor function. Recent studies, however, reveal that deterioration of cognitive function, fatigue, pain, and depression also occur in BMS patients, causing negative impact on work and social activities, despite complete preservation of motor function. Using conventional MRI techniques, lesion load observed in BMS is similar to levels in other disease subtypes; however, newer quantitative MRI techniques show less tissue damage, as well as greater repair and compensatory efficiency following MS injury. Currently accepted criteria for BMS diagnosis may cause overestimation of true prevalence, underscoring the need for routine monitoring of nonmotor symptoms and imaging studies. Clearly, the definition of BMS currently applied in clinical practice requires reassessment.

Entities:  

Mesh:

Year:  2012        PMID: 22777531     DOI: 10.1007/s11910-012-0292-5

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  88 in total

1.  A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials.

Authors:  M P Amato; G Ponziani; M L Bartolozzi; G Siracusa
Journal:  J Neurol Sci       Date:  1999-10-15       Impact factor: 3.181

2.  The HLA-DR13 haplotype is associated with "benign" multiple sclerosis in northeast Italy.

Authors:  P Perini; C Tagliaferri; M Belloni; G Biasi; P Gallo
Journal:  Neurology       Date:  2001-07-10       Impact factor: 9.910

3.  The natural history of untreated multiple sclerosis in Iceland. A total population-based 50 year prospective study.

Authors:  John Benedikz; Magnūs Stefánsson; Jūlíus Guomundsson; Aoalbjörg Jónasdóttir; Ragnheiour Fossdal; Jeff Gulcher; Kāri Stefánsson
Journal:  Clin Neurol Neurosurg       Date:  2002-07       Impact factor: 1.876

Review 4.  Benign course in multiple sclerosis: a review.

Authors:  G S M Ramsaransing; J De Keyser
Journal:  Acta Neurol Scand       Date:  2006-06       Impact factor: 3.209

5.  Simplified MRI prediction of clinically definite multiple sclerosis: a stepping stone towards treatment criteria?

Authors:  Charles Rg Guttmann
Journal:  Nat Clin Pract Neurol       Date:  2008-01-22

6.  Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.

Authors:  Nicola De Stefano; Marco Battaglini; M L Stromillo; Valentina Zipoli; M L Bartolozzi; Leonello Guidi; Gianfranco Siracusa; Emilio Portaccio; Antonio Giorgio; Sandro Sorbi; Antonio Federico; Maria Pia Amato
Journal:  Brain       Date:  2006-06-30       Impact factor: 13.501

7.  A clinical and laboratory study of benign multiple sclerosis.

Authors:  A J Thompson; M Hutchinson; J Brazil; C Feighery; E A Martin
Journal:  Q J Med       Date:  1986-01

8.  Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up.

Authors:  B Runmarker; O Andersen
Journal:  Brain       Date:  1993-02       Impact factor: 13.501

9.  Longitudinal follow-up of "benign" multiple sclerosis at 20 years.

Authors:  Ana-Luiza Sayao; Virginia Devonshire; Helen Tremlett
Journal:  Neurology       Date:  2007-02-13       Impact factor: 9.910

10.  Rate of brain atrophy in benign vs early multiple sclerosis.

Authors:  Susan A Gauthier; Annika M Berger; Zsuzsanna Liptak; Yang Duan; Svetlana Egorova; Guy J Buckle; Bonnie I Glanz; Samia J Khoury; Rohit Bakshi; Howard L Weiner; Charles R G Guttmann
Journal:  Arch Neurol       Date:  2009-02
View more
  7 in total

Review 1.  Multiple sclerosis-a quiet revolution.

Authors:  Richard M Ransohoff; David A Hafler; Claudia F Lucchinetti
Journal:  Nat Rev Neurol       Date:  2015-02-17       Impact factor: 42.937

2.  Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disability.

Authors:  Ashley D Radomski; Christopher Power; Scot E Purdon; Derek J Emery; Gregg Blevins; Kenneth G Warren; Esther Fujiwara
Journal:  BMC Neurol       Date:  2015-04-23       Impact factor: 2.474

3.  Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC).

Authors:  Robert Zivadinov; Diane L Cookfair; Lauren Krupp; Aaron E Miller; Neil Lava; Patricia K Coyle; Andrew D Goodman; Burk Jubelt; Michael Lenihan; Joseph Herbert; Malcolm Gottesman; David H Snyder; Brian R Apatoff; Barbara E Teter; Allan B Perel; Frederick Munschauer; Bianca Weinstock-Guttman
Journal:  BMC Neurol       Date:  2016-07-15       Impact factor: 2.474

4.  Expanded Disability Status Scale-Based Disability and Dental-Periodontal Conditions in Patients with Multiple Sclerosis.

Authors:  Hasan Hatipoglu; Sibel Canbaz Kabay; Mujgan Gungor Hatipoglu; Hilmi Ozden
Journal:  Med Princ Pract       Date:  2015-10-17       Impact factor: 1.927

Review 5.  Repetitive Transcranial Magnetic Stimulation, Cognition, and Multiple Sclerosis: An Overview.

Authors:  Grigorios Nasios; Lambros Messinis; Efthimios Dardiotis; Panagiotis Papathanasopoulos
Journal:  Behav Neurol       Date:  2018-01-18       Impact factor: 3.342

6.  Impairment and restrictions in possibly benign multiple sclerosis.

Authors:  Laura Melanie Schaefer; Jana Poettgen; Anja Fischer; Stefan Gold; Jan-Patrick Stellmann; Christoph Heesen
Journal:  Brain Behav       Date:  2019-03-18       Impact factor: 2.708

7.  Grey matter atrophy in patients with benign multiple sclerosis.

Authors:  Marja Niiranen; Juha Koikkalainen; Jyrki Lötjönen; Tuomas Selander; Antti Cajanus; Päivi Hartikainen; Sakari Simula; Ritva Vanninen; Anne M Remes
Journal:  Brain Behav       Date:  2022-06-28       Impact factor: 3.405

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.